Erik Amble
Gründer bei Neomed Management AS
Aktive Positionen von Erik Amble
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Neomed Management AS
Neomed Management AS Investment ManagersFinance Neomed Management AS is an investment firm based in Oslo. Founded in 1998, the firm specializes in private equity investments in the healthcare and life science sectors. Neomed advises several funds namely NeoMed I, II, III, IV and V. | Gründer | 09.02.1998 | - |
Vorsitzender | 30.11.2016 | - | |
Private Equity Investor | 09.02.1998 | - | |
Vorstandsvorsitzender | 09.02.1998 | 30.11.2016 | |
JenaValve Technology GmbH
JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | Direktor/Vorstandsmitglied | - | - |
Sequana Medical AG
Sequana Medical AG Medical SpecialtiesHealth Technology Sequana Medical AG operates as a medical device company. It specializes in the production and design of implantable pump systems to manage fluid balance within the body. The firm offers the Alfapump system, its proprietary solution to manage and remove ascites, which can occur as a symptom of liver disease, cancer, or congestive heart failure and its focus areas encompass clinical research, product innovation, and technology development. The company was founded by Noel L. Johnson in 2000 and is headquartered in Zurich, Switzerland. | Direktor/Vorstandsmitglied | - | - |
Corflow Therapeutics AG
Corflow Therapeutics AG Medical SpecialtiesHealth Technology Corflow Therapeutics AG is a company based in Switzerland that is developing proprietary technologies to measure the coronary microvascular status and provide therapy to the compromised coronary microcirculation at the same time in the catheter laboratory. The Swiss company's focus is on treating microvascular obstruction (MVO) after an acute heart attack, which is documented to be an independent marker leading to costly complications such as heart failure. Corflow's technologies may enable interventional cardiologists to treat MVO in severe heart attack patients, thereby potentially reducing the short- and long-term complication rates in these patients. The company was founded in 2016 by Martin T. Rothman and Robert S. Schwartz. | Direktor/Vorstandsmitglied | - | - |
Serca Pharmaceuticals AS
Serca Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Serca Pharmaceuticals AS develops, markets, and sells drug treatment products, medicinal products, and equipment for injuries. The company was founded on October 8, 2018 and is headquartered in Lysaker, Norway. | Direktor/Vorstandsmitglied | - | - |
JenaValve Technology, Inc.
JenaValve Technology, Inc. Medical SpecialtiesHealth Technology JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Erik Amble
Ehemalige bekannte Positionen von Erik Amble
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SEQUANA MEDICAL N.V. | Direktor/Vorstandsmitglied | - | 07.09.2022 |
AXONICS, INC. | Direktor/Vorstandsmitglied | 01.03.2014 | 31.12.2020 |
Independent Dir/Board Member | 01.03.2014 | 31.12.2020 | |
Windy Hill Medical, Inc.
Windy Hill Medical, Inc. Medical SpecialtiesHealth Technology Windy Hill Medical, Inc. manufactures and supplies medical devices. The firm focuses on the development of products to reduce the risk of breast cancer. The company was founded by Dr. Susan Love in 2004 and is headquartered in Laguna Hills, CA. | Direktor/Vorstandsmitglied | - | 28.05.2012 |
░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░ ░░░░░░░ ░░░░░░░ ░ ░░░░░░░ ░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░ | - | - |
░░░░░░░ | - | - | |
░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░ | - | - |
░░░░░ ░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░░ ░ ░░░░░░░ | - | - |
░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Ausbildung von Erik Amble
University of Oslo | Doctorate Degree |
Stanford Graduate School of Business | Graduate Degree |
Statistik
International
Norwegen | 10 |
Vereinigte Staaten | 9 |
Schweiz | 4 |
Operativ
Director/Board Member | 16 |
Chairman | 2 |
Founder | 2 |
Sektoral
Health Technology | 15 |
Finance | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
SONENDO, INC. | Health Technology |
FLERIE INVEST AB | Health Technology |
AXONICS, INC. | Health Technology |
SEQUANA MEDICAL N.V. | Health Technology |
Private Unternehmen | 17 |
---|---|
Windy Hill Medical, Inc.
Windy Hill Medical, Inc. Medical SpecialtiesHealth Technology Windy Hill Medical, Inc. manufactures and supplies medical devices. The firm focuses on the development of products to reduce the risk of breast cancer. The company was founded by Dr. Susan Love in 2004 and is headquartered in Laguna Hills, CA. | Health Technology |
Thommen Medical AG
Thommen Medical AG Medical SpecialtiesHealth Technology Thommen Medical AG develops and manufactures dental implant systems. It offers include implants, prosthetics, digital solutions, and case planning. The company Grenchen, Switzerland. | Health Technology |
GenoVision AS
GenoVision AS Medical SpecialtiesHealth Technology GenoVision AS develops reagents and solutions for certain nucleic acid diagnostic markets. It has developed products and protocols for the direct isolation of DNA and RNA from a variety of sample sources such as dried blood, leucocytes, serum, buccal cells, cultured cells, biopsy samples, paraffin embedded tissue sections, animal tissue and yeast cells. GenoVision was formed in 1998 and is headquartered in Oslo, Norway | Health Technology |
Weifa ASA
Weifa ASA Pharmaceuticals: MajorHealth Technology Weifa ASA engages in the development, production and sales of medicines and other health products. Its products include medicines for pain relief, cough and cold, nutraceuticals, and dermatology. The company was founded by Olaf Weider in 1940 and is headquartered in Oslo, Norway. | Health Technology |
Neomed Management AS
Neomed Management AS Investment ManagersFinance Neomed Management AS is an investment firm based in Oslo. Founded in 1998, the firm specializes in private equity investments in the healthcare and life science sectors. Neomed advises several funds namely NeoMed I, II, III, IV and V. | Finance |
JenaValve Technology GmbH
JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | Health Technology |
Alertis Medical AS
Alertis Medical AS Medical DistributorsDistribution Services Alertis Medical AS was established in 2000 to develop and commercialize a unique technology for the early detection of critical conditions related to blood supply and respiration, addressing considerable unmet needs in medicine. The patented technology originates from the anesthesiologist Prof T. I. Tønnessen, MD, PhD, and the physicist P. Mirtaheri, PhD, at Rikshospitalet University Hospital, Oslo | Distribution Services |
Vessix Vascular, Inc.
Vessix Vascular, Inc. Pharmaceuticals: OtherHealth Technology Vessix Vascular, Inc. develops products to treat artery disease. The company was founded in 2003 and is headquartered in Laguna Hills, CA. | Health Technology |
Sequana Medical AG
Sequana Medical AG Medical SpecialtiesHealth Technology Sequana Medical AG operates as a medical device company. It specializes in the production and design of implantable pump systems to manage fluid balance within the body. The firm offers the Alfapump system, its proprietary solution to manage and remove ascites, which can occur as a symptom of liver disease, cancer, or congestive heart failure and its focus areas encompass clinical research, product innovation, and technology development. The company was founded by Noel L. Johnson in 2000 and is headquartered in Zurich, Switzerland. | Health Technology |
Glenwood Management
Glenwood Management Real Estate DevelopmentFinance Glenwood Management develops, owns, manages, and rents apartments. The private company is based in New York, NY and has subsidiaries in the United States. | Finance |
JenaValve Technology, Inc.
JenaValve Technology, Inc. Medical SpecialtiesHealth Technology JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE. | Health Technology |
Norwegian Venture Capital & Private Equity Association | |
Omega Fund Management LLC
Omega Fund Management LLC Investment ManagersFinance Omega Fund Management Ltd. (OFM) is the wholly-owned private equity firm founded by Dr. Otello Stampacchia in 2004. The firm is headquartered in the US. | Finance |
Qiagen AS | |
Corflow Therapeutics AG
Corflow Therapeutics AG Medical SpecialtiesHealth Technology Corflow Therapeutics AG is a company based in Switzerland that is developing proprietary technologies to measure the coronary microvascular status and provide therapy to the compromised coronary microcirculation at the same time in the catheter laboratory. The Swiss company's focus is on treating microvascular obstruction (MVO) after an acute heart attack, which is documented to be an independent marker leading to costly complications such as heart failure. Corflow's technologies may enable interventional cardiologists to treat MVO in severe heart attack patients, thereby potentially reducing the short- and long-term complication rates in these patients. The company was founded in 2016 by Martin T. Rothman and Robert S. Schwartz. | Health Technology |
Serca Pharmaceuticals AS
Serca Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Serca Pharmaceuticals AS develops, markets, and sells drug treatment products, medicinal products, and equipment for injuries. The company was founded on October 8, 2018 and is headquartered in Lysaker, Norway. | Health Technology |
Origo Ventures AS |
- Börse
- Insiders
- Erik Amble
- Erfahrung